" class="no-js "lang="en-US"> NEC Corporation - Pharmtech Focus
Tuesday, January 31, 2023
NEC Corporation | Pharmtech Focus

NEC Corporation

About NEC Corporation

NEC Corporation

NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at http://www.nec.com

NEC’s Strengths and Competencies
・Named “2017 Global 100 Most Sustainable Corporations in the World”​ an Index Listing the World’s 100 Most Sustainable Corporations
・Named one of the “World’s Top 100 Most Innovative Organizations for 2016″​ by Thomson Reuters
・Face recognition technology achieved No. 1 in the recent Face in Video Evaluation (FIVE, *1) testing performed by the U.S. National Institute of Standards and Technology (NIST) (*2)

(*1) https://www.nist.gov/programs-projects/face-video-evaluation-five
(*2) Results shown from the Face In Video Evaluation (FIVE), the Multiple Biometric Grand Challenge (MBGC), the Multiple Biometric Evaluation (MBE) and the Face Recognition Vendor Test (FRVT) do not constitute endorsement of any particular product by the U.S. Government.

Related Story

NEC OncoImmunity Acquires VAXIMM's Neoantigen Vaccine Development Assets

March 9 2022

NEC OncoImmunity (NOI), a subsidiary of NEC Corporation (NEC), and VAXIMM AG, a Swiss/German biotech […]

BostonGene and NEC Announce Global Partnership

December 15 2021

BostonGene Corporation and NEC Corporation (TSE: 6701) today announced a strategic global partnership agreement that will […]

Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine

November 23 2021

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment […]